Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:19 AM
Ignite Modification Date:
2025-12-25 @ 12:19 AM
NCT ID:
NCT01078558
Eligibility Criteria:
Inclusion Criteria:
* Patients with ongoing HUMIRA (adalimumab) treatment who have been prescribed HUMIRA (adalimumab) within local reimbursement guidelines.
* Patients must be willing to consent to data being collected and provided to Abbott Laboratories.
Exclusion Criteria:
* Contraindications according to the summary of product characteristics.
* Patients who are actually followed in the ReAlise registry (M03-634 NCT00234884).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
99 Years
Study:
NCT01078558
Study Brief:
Protocol Section:
NCT01078558